68 related articles for article (PubMed ID: 37474689)
1. Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer.
Huang H; Pan Y; Huang J; Zhang C; Liao Y; Du Q; Qin S; Chen Y; Tan H; Chen M; Xu M; Xia M; Liu Y; Li J; Liu T; Zou Q; Zhou Y; Yuan L; Wang W; Liang Y; Pan CY; Liu J; Yao S
iScience; 2023 Nov; 26(11):108198. PubMed ID: 38026204
[TBL] [Abstract][Full Text] [Related]
2. Efficient Establishment of Bile-Derived Organoids From Biliary Cancer Patients.
Kinoshita K; Tsukamoto Y; Hirashita Y; Fuchino T; Kurogi S; Uchida T; Nakada C; Matsumoto T; Okamoto K; Motomura M; Fukuchi S; Sagami R; Nagai T; Gotoh Y; Fukuda K; Ogawa R; Mizukami K; Okimoto T; Kodama M; Murakami K; Moriyama M; Hijiya N
Lab Invest; 2023 Jun; 103(6):100105. PubMed ID: 36842278
[TBL] [Abstract][Full Text] [Related]
3. Lung Cancer Organoids as Avatars of Patients With Lung Cancer in the Prediction of Therapeutic Response.
Rosell R; Pedraz-Valdunciel C
JTO Clin Res Rep; 2023 Oct; 4(10):100571. PubMed ID: 37842325
[No Abstract] [Full Text] [Related]
4. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology.
Ji S; Feng L; Fu Z; Wu G; Wu Y; Lin Y; Lu D; Song Y; Cui P; Yang Z; Sang C; Song G; Cai S; Li Y; Lin H; Zhang S; Wang X; Qiu S; Zhang X; Hua G; Li J; Zhou J; Dai Z; Wang X; Ding L; Wang P; Gao D; Zhang B; Rodriguez H; Fan J; Clevers H; Zhou H; Sun Y; Gao Q
Sci Transl Med; 2023 Jul; 15(706):eadg3358. PubMed ID: 37494474
[TBL] [Abstract][Full Text] [Related]
5. Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer.
Önder CE; Ziegler TJ; Becker R; Brucker SY; Hartkopf AD; Engler T; Koch A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509265
[TBL] [Abstract][Full Text] [Related]
6. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY
Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597
[TBL] [Abstract][Full Text] [Related]
7. Organoid models for translational pancreatic cancer research.
Tiriac H; Plenker D; Baker LA; Tuveson DA
Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513
[TBL] [Abstract][Full Text] [Related]
8. Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids.
Wu YH; Chao HS; Chiang CL; Luo YH; Chiu CH; Yen SH; Liu CY; Chiou JF; Burnouf T; Chen YJ; Wang PY; Chao TY; Hsu SM; Lu LS
Thorac Cancer; 2023 Sep; 14(25):2591-2600. PubMed ID: 37474689
[TBL] [Abstract][Full Text] [Related]
9. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma.
Wu YH; Hung YP; Chiu NC; Lee RC; Li CP; Chao Y; Shyr YM; Wang SE; Chen SC; Lin SH; Chen YH; Kang YM; Hsu SM; Yen SH; Wu JY; Lee KD; Tseng HE; Tsai JR; Tang JH; Chiou JF; Burnouf T; Chen YJ; Wang PY; Lu LS
Eur J Cancer; 2022 May; 166():208-218. PubMed ID: 35306319
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
12. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.
Grossman JE; Muthuswamy L; Huang L; Akshinthala D; Perea S; Gonzalez RS; Tsai LL; Cohen J; Bockorny B; Bullock AJ; Schlechter B; Peters MLB; Conahan C; Narasimhan S; Lim C; Davis RB; Besaw R; Sawhney MS; Pleskow D; Berzin TM; Smith M; Kent TS; Callery M; Muthuswamy SK; Hidalgo M
Clin Cancer Res; 2022 Feb; 28(4):708-718. PubMed ID: 34789479
[TBL] [Abstract][Full Text] [Related]
13. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
14. WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells
Zhang X; Schalke B; Kvell K; Kriegsmann K; Kriegsmann M; Graeter T; Preissler G; Ott G; Kurz K; Bulut E; Ströbel P; Marx A; Belharazem D
Front Oncol; 2022; 12():920871. PubMed ID: 35965500
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
